News | August 04, 2008

New GE CT Scanner Technology Captures Rodent Heart Beat at 600 Beats-Per-Minute

August 5, 2008 - GE Healthcare today released a new pre-clinical computed tomography scanner specifically designed to accelerate research in the areas of cardiac disease and drug development.

The GE eXplore CT 120 scanner is an all-new design based on years of research CT scanner experience, GE officials said. Using X-ray source technology derived from clinical systems, the eXplore CT 120 features 100 times the output of previous GE laboratory research imaging systems. This power enables X-ray exposures fast enough and detailed enough to capture the motion of a beating mouse heart, and brings the power of cardiac CT imaging to a popular mammal used in disease research and drug development.

The power of the new X-ray source also allows for more effective filtering of the X-ray beam, reducing the X-ray dose to the research subject compared to previous scanners, while greatly reducing the scan time.

“Morphological imaging is the key to understanding cardiac kinetics,” said Professor André Constantinesco of Hôpitaux Universitaires de Strasbourg. “This scanner provides us the ability to acquire 4D, high-resolution datasets in living mice, improving our ability to quantify rodent models of cardiac diseases.”

The scanner’s user software is designed for throughput and, with its powerful computing hardware, makes the scanner four times faster than previous designs. Industry-standard DICOM compatibility and an optional analysis workstation assist in timely image analysis and production of research data.

For more information: www.gehealthcare.com

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Overlay Init